Conference call regarding interim report Q2
11 augusti, 10:00
Invitation to attend Surgical Science's conference call regarding presentation of the interim report January-June 2025. The presentation will be held in English.
Time: Thursday, August 21 at 11:00 a.m. CET
If you wish to participate via webcast, please use the link below. It will be possible to ask written questions via the webcast.
https://surgical-science-sweden.events.inderes.com/q2-report-2025
If you wish to participate via teleconference, please register via the link below. After registration, you will receive phone number and a conference ID to access the conference. It will be possible to ask oral questions via the telephone conference.
https://events.inderes.com/surgical-science-sweden/q2-report-2025/dial-in
Participants from Surgical Science are:
Tom Englund, CEO
Anna Ahlberg, CFO
A press release with Surgical Science's interim report for January-June 2025 will be published on August 21, 2025 at 07:30 a.m. CET.
Prior to the start of the conference call, presentation material will be available on the company's website, under Investors, Presentations.
Gothenburg, Sweden, August 11, 2025
Surgical Science Sweden AB (publ)
The press release, in its entirety, is available through the attachment or via:
https://surgicalscience.com/investor-relations/#press-releases
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
For further information, please contact:
Tom Englund, CEO
Telephone: +46-70-916 16 81
E-mail: tom.englund@surgicalscience.com
Anna Ahlberg, CFO
Telephone: +46-70-855 38 35
E-mail: anna.ahlberg@surgicalscience.com
About Surgical Science Sweden AB (publ)
One of the biggest challenges within healthcare globally is reducing injuries incurred during care. Medical education and training are key, especially as a large part of the training can now be performed outside the operating room. Surgical Science is a world leader in the development of virtual reality simulators for evidence-based training. The simulators enable surgeons and other medical specialists to train and improve their psycho-motor skills and instrument handling before entering the clinical environment. Alongside its own products, Surgical Science works with simulation solutions for medical device companies that develop instruments for clinical use, such as robotic surgery.
Surgical Science has approximately 330 employees. The company is headquartered in Gothenburg, Sweden, and has operations in Tel Aviv, Israel; Stockholm, Sweden; Seattle and Cleveland, US; and Cardiff, UK. Through sales offices in the US and China as well as a global network of distributors, Surgical Science maintains a presence in most markets. Shares in Surgical Science Sweden AB (publ) are traded on Nasdaq First North Growth Market. Certified Adviser is DNB Carnegie Investment Bank AB.
Attachments
Ämnen i artikeln
Conference call regarding interim report Q2
11 augusti, 10:00
Invitation to attend Surgical Science's conference call regarding presentation of the interim report January-June 2025. The presentation will be held in English.
Time: Thursday, August 21 at 11:00 a.m. CET
If you wish to participate via webcast, please use the link below. It will be possible to ask written questions via the webcast.
https://surgical-science-sweden.events.inderes.com/q2-report-2025
If you wish to participate via teleconference, please register via the link below. After registration, you will receive phone number and a conference ID to access the conference. It will be possible to ask oral questions via the telephone conference.
https://events.inderes.com/surgical-science-sweden/q2-report-2025/dial-in
Participants from Surgical Science are:
Tom Englund, CEO
Anna Ahlberg, CFO
A press release with Surgical Science's interim report for January-June 2025 will be published on August 21, 2025 at 07:30 a.m. CET.
Prior to the start of the conference call, presentation material will be available on the company's website, under Investors, Presentations.
Gothenburg, Sweden, August 11, 2025
Surgical Science Sweden AB (publ)
The press release, in its entirety, is available through the attachment or via:
https://surgicalscience.com/investor-relations/#press-releases
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
For further information, please contact:
Tom Englund, CEO
Telephone: +46-70-916 16 81
E-mail: tom.englund@surgicalscience.com
Anna Ahlberg, CFO
Telephone: +46-70-855 38 35
E-mail: anna.ahlberg@surgicalscience.com
About Surgical Science Sweden AB (publ)
One of the biggest challenges within healthcare globally is reducing injuries incurred during care. Medical education and training are key, especially as a large part of the training can now be performed outside the operating room. Surgical Science is a world leader in the development of virtual reality simulators for evidence-based training. The simulators enable surgeons and other medical specialists to train and improve their psycho-motor skills and instrument handling before entering the clinical environment. Alongside its own products, Surgical Science works with simulation solutions for medical device companies that develop instruments for clinical use, such as robotic surgery.
Surgical Science has approximately 330 employees. The company is headquartered in Gothenburg, Sweden, and has operations in Tel Aviv, Israel; Stockholm, Sweden; Seattle and Cleveland, US; and Cardiff, UK. Through sales offices in the US and China as well as a global network of distributors, Surgical Science maintains a presence in most markets. Shares in Surgical Science Sweden AB (publ) are traded on Nasdaq First North Growth Market. Certified Adviser is DNB Carnegie Investment Bank AB.
Attachments
Ämnen i artikeln
Börsernas utveckling
Wingefors försäljning
Börsen
Styrräntan
Aktieanalyser
Börsernas utveckling
Wingefors försäljning
Börsen
Mest läst
Styrräntan
Aktieanalyser
Marknadsöversikt
1 DAG %
Senast
1 mån
Privatekonomi med Placeras expert
Affärsvärlden
